233 related articles for article (PubMed ID: 29208670)
1. Inhibition of ID1-BMPR2 Intrinsic Signaling Sensitizes Glioma Stem Cells to Differentiation Therapy.
Jin X; Jin X; Kim LJY; Dixit D; Jeon HY; Kim EJ; Kim JK; Lee SY; Yin J; Rich JN; Kim H
Clin Cancer Res; 2018 Jan; 24(2):383-394. PubMed ID: 29208670
[No Abstract] [Full Text] [Related]
2. The ID1-CULLIN3 Axis Regulates Intracellular SHH and WNT Signaling in Glioblastoma Stem Cells.
Jin X; Jeon HM; Jin X; Kim EJ; Yin J; Jeon HY; Sohn YW; Oh SY; Kim JK; Kim SH; Jung JE; Kwak S; Tang KF; Xu Y; Rich JN; Kim H
Cell Rep; 2016 Aug; 16(6):1629-1641. PubMed ID: 27477274
[TBL] [Abstract][Full Text] [Related]
3. Small molecule antagonist of the bone morphogenetic protein type I receptors suppresses growth and expression of Id1 and Id3 in lung cancer cells expressing Oct4 or nestin.
Langenfeld E; Deen M; Zachariah E; Langenfeld J
Mol Cancer; 2013 Oct; 12(1):129. PubMed ID: 24160469
[TBL] [Abstract][Full Text] [Related]
4. TGM2 inhibition attenuates ID1 expression in CD44-high glioma-initiating cells.
Fu J; Yang QY; Sai K; Chen FR; Pang JC; Ng HK; Kwan AL; Chen ZP
Neuro Oncol; 2013 Oct; 15(10):1353-65. PubMed ID: 23877317
[TBL] [Abstract][Full Text] [Related]
5. Dual inhibition of Src and PLK1 regulate stemness and induce apoptosis through Notch1-SOX2 signaling in EGFRvIII positive glioma stem cells (GSCs).
Li X; Tao Z; Wang H; Deng Z; Zhou Y; Du Z
Exp Cell Res; 2020 Nov; 396(1):112261. PubMed ID: 32896567
[TBL] [Abstract][Full Text] [Related]
6. BMP9-ID1 signaling promotes EpCAM-positive cancer stem cell properties in hepatocellular carcinoma.
Chen H; Nio K; Yamashita T; Okada H; Li R; Suda T; Li Y; Doan PTB; Seki A; Nakagawa H; Toyama T; Terashima T; Iida N; Shimakami T; Takatori H; Kawaguchi K; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
Mol Oncol; 2021 Aug; 15(8):2203-2218. PubMed ID: 33834612
[TBL] [Abstract][Full Text] [Related]
7. Self-renewal does not predict tumor growth potential in mouse models of high-grade glioma.
Barrett LE; Granot Z; Coker C; Iavarone A; Hambardzumyan D; Holland EC; Nam HS; Benezra R
Cancer Cell; 2012 Jan; 21(1):11-24. PubMed ID: 22264785
[TBL] [Abstract][Full Text] [Related]
8. Activation of estrogen receptor beta signaling reduces stemness of glioma stem cells.
Sareddy GR; Pratap UP; Venkata PP; Zhou M; Alejo S; Viswanadhapalli S; Tekmal RR; Brenner AJ; Vadlamudi RK
Stem Cells; 2021 May; 39(5):536-550. PubMed ID: 33470499
[TBL] [Abstract][Full Text] [Related]
9. Id1-induced IGF-II and its autocrine/endocrine promotion of esophageal cancer progression and chemoresistance--implications for IGF-II and IGF-IR-targeted therapy.
Li B; Tsao SW; Chan KW; Ludwig DL; Novosyadlyy R; Li YY; He QY; Cheung AL
Clin Cancer Res; 2014 May; 20(10):2651-62. PubMed ID: 24599933
[TBL] [Abstract][Full Text] [Related]
10. A new 2-pyrone derivative, 5-bromo-3-(3-hydroxyprop-1-ynyl)-2H-pyran-2-one, suppresses stemness in glioma stem-like cells.
Kim RK; Kim MJ; Yoon CH; Lim EJ; Yoo KC; Lee GH; Kim YH; Kim H; Jin YB; Lee YJ; Cho CG; Oh YS; Gye MC; Suh Y; Lee SJ
Mol Pharmacol; 2012 Sep; 82(3):400-7. PubMed ID: 22648970
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of BMP and of TGFβ receptors downregulates expression of XIAP and TAK1 leading to lung cancer cell death.
Augeri DJ; Langenfeld E; Castle M; Gilleran JA; Langenfeld J
Mol Cancer; 2016 Apr; 15():27. PubMed ID: 27048361
[TBL] [Abstract][Full Text] [Related]
12. QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.
Han B; Wang R; Chen Y; Meng X; Wu P; Li Z; Duan C; Li Q; Li Y; Zhao S; Jiang C; Cai J
Cell Oncol (Dordr); 2019 Dec; 42(6):801-813. PubMed ID: 31292920
[TBL] [Abstract][Full Text] [Related]
13. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
Prabhu VV; Lulla AR; Madhukar NS; Ralff MD; Zhao D; Kline CLB; Van den Heuvel APJ; Lev A; Garnett MJ; McDermott U; Benes CH; Batchelor TT; Chi AS; Elemento O; Allen JE; El-Deiry WS
PLoS One; 2017; 12(8):e0180541. PubMed ID: 28767654
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Id1 in transgenic mice promotes mammary basal stem cell activity and breast tumorigenesis.
Shin DH; Park JH; Lee JY; Won HY; Jang KS; Min KW; Jang SH; Woo JK; Oh SH; Kong G
Oncotarget; 2015 Jul; 6(19):17276-90. PubMed ID: 25938540
[TBL] [Abstract][Full Text] [Related]
16. Glioma-derived cancer stem cells are hypersensitive to proteasomal inhibition.
Yoo YD; Lee DH; Cha-Molstad H; Kim H; Mun SR; Ji C; Park SH; Sung KS; Choi SA; Hwang J; Park DM; Kim SK; Park KJ; Kang SH; Oh SC; Ciechanover A; Lee YJ; Kim BY; Kwon YT
EMBO Rep; 2017 Jan; 18(1):150-168. PubMed ID: 27993939
[TBL] [Abstract][Full Text] [Related]
17. The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties.
Manrique I; Nguewa P; Bleau AM; Nistal-Villan E; Lopez I; Villalba M; Gil-Bazo I; Calvo A
Cancer Lett; 2015 Jan; 356(2 Pt B):899-909. PubMed ID: 25449776
[TBL] [Abstract][Full Text] [Related]
18. SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation via miR-21/BMPRII/Id1 Signaling Pathway.
Li F; Wang J; Zhu Y; Liu L; Feng W; Shi W; Wang Q; Zhang Q; Chai L; Li M
Cell Physiol Biochem; 2018; 51(1):487-500. PubMed ID: 30453304
[TBL] [Abstract][Full Text] [Related]
19. Addiction to the IGF2-ID1-IGF2 circuit for maintenance of the breast cancer stem-like cells.
Tominaga K; Shimamura T; Kimura N; Murayama T; Matsubara D; Kanauchi H; Niida A; Shimizu S; Nishioka K; Tsuji EI; Yano M; Sugano S; Shimono Y; Ishii H; Saya H; Mori M; Akashi K; Tada KI; Ogawa T; Tojo A; Miyano S; Gotoh N
Oncogene; 2017 Mar; 36(9):1276-1286. PubMed ID: 27546618
[TBL] [Abstract][Full Text] [Related]
20. The miR-371∼373 Cluster Represses Colon Cancer Initiation and Metastatic Colonization by Inhibiting the TGFBR2/ID1 Signaling Axis.
Ullmann P; Rodriguez F; Schmitz M; Meurer SK; Qureshi-Baig K; Felten P; Ginolhac A; Antunes L; Frasquilho S; Zügel N; Weiskirchen R; Haan S; Letellier E
Cancer Res; 2018 Jul; 78(14):3793-3808. PubMed ID: 29748374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
